Cooper Companies Sees Unusually Large Options Volume (NASDAQ:COO)

The Cooper Companies, Inc. (NASDAQ:COO) was the recipient of unusually large options trading on Tuesday. Stock investors purchased 4,056 call options on the stock. This is an increase of approximately 411% compared to the typical volume of 794 call options.

Analysts Set New Price Targets

COO has been the subject of a number of recent research reports. Wall Street Zen upgraded shares of Cooper Companies from a “hold” rating to a “buy” rating in a report on Sunday, June 21st. Citigroup reiterated a “neutral” rating and issued a $80.00 price objective (up from $76.00) on shares of Cooper Companies in a report on Thursday, August 13th. UBS Group initiated coverage on shares of Cooper Companies in a research note on Tuesday, July 28th. They set a “neutral” rating and a $75.00 target price on the stock. Weiss Ratings lowered Cooper Companies from a “hold (c-)” rating to a “sell (d)” rating in a research report on Monday, June 8th. Finally, Wells Fargo & Company restated a “sell” rating and issued a $66.00 price objective (down from $82.00) on shares of Cooper Companies in a report on Friday, June 5th. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, six have assigned a Hold rating and three have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $81.64.

Institutional Trading of Cooper Companies

Several hedge funds have recently bought and sold shares of COO. Avalon Trust Co purchased a new stake in Cooper Companies in the second quarter worth about $25,000. Root Financial Partners LLC lifted its position in shares of Cooper Companies by 104.5% during the 4th quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock valued at $26,000 after buying an additional 162 shares in the last quarter. SJS Investment Consulting Inc. grew its stake in shares of Cooper Companies by 107.5% during the 1st quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company’s stock valued at $26,000 after acquiring an additional 187 shares during the period. Elevation Wealth Partners LLC increased its holdings in Cooper Companies by 1,136.4% in the 2nd quarter. Elevation Wealth Partners LLC now owns 408 shares of the medical device company’s stock worth $29,000 after acquiring an additional 375 shares in the last quarter. Finally, Continuum Advisory LLC purchased a new stake in Cooper Companies in the 2nd quarter worth approximately $30,000. Institutional investors own 24.39% of the company’s stock.

Cooper Companies Stock Performance

Cooper Companies stock traded down $1.84 during mid-day trading on Tuesday, reaching $73.96. 126,403 shares of the stock traded hands, compared to its average volume of 2,335,153. Cooper Companies has a 12-month low of $58.89 and a 12-month high of $89.83. The stock has a market capitalization of $14.42 billion, a PE ratio of 62.67, a price-to-earnings-growth ratio of 1.99 and a beta of 0.83. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.27 and a quick ratio of 0.78. The business’s 50-day moving average is $72.09 and its 200-day moving average is $71.07.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings data on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.10 by $0.11. The company had revenue of $1.08 billion for the quarter, compared to the consensus estimate of $1.05 billion. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The firm’s revenue was up 7.9% compared to the same quarter last year. During the same quarter last year, the firm posted $0.96 earnings per share. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. As a group, sell-side analysts predict that Cooper Companies will post 4.63 EPS for the current fiscal year.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.